» Articles » PMID: 31879084

Panel 4: Recent Advances in Understanding the Natural History of the Otitis Media Microbiome and Its Response to Environmental Pressures

Overview
Specialty Pediatrics
Date 2019 Dec 28
PMID 31879084
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To perform a comprehensive review of otitis media microbiome literature published between 1 July 2015 and 30th June 2019.

Data Sources: PubMed database, National Library of Medicine.

Review Methods: Key topics were assigned to each panel member for detailed review. Draft reviews were collated and circulated for discussion when the panel met at the 20th International Symposium on Recent Advances in Otitis Media in June 2019. The final draft was prepared with input from all panel members.

Conclusions: Much has been learned about the different types of bacteria (including commensals) present in the upper respiratory microbiome, but little is known about the virome and mycobiome. A small number of studies have investigated the middle ear microbiome; however, current data are often limited by small sample sizes and methodological heterogeneity between studies. Furthermore, limited reporting of sample collection methods mean that it is often difficult to determine whether bacteria detected in middle ear fluid specimens originated from the middle ear or the external auditory canal. Recent in vitro studies suggest that bacterial interactions in the nasal/nasopharyngeal microbiome may affect otitis media pathogenesis by modifying otopathogen behaviours. Impacts of environmental pressures (e.g. smoke, nutrition) and clinical interventions (e.g. vaccination, antibiotics) on the upper respiratory and middle ear microbiomes remain poorly understood as there are few data.

Implications For Practice: Advances in understanding bacterial dynamics in the upper airway microbiome are driving development of microbiota-modifying therapies to prevent or treat disease (e.g. probiotics). Further advances in otitis media microbiomics will likely require technological improvements that overcome the current limitations of OMICs technologies when applied to low volume and low biomass specimens that potentially contain high numbers of host cells. Improved laboratory models are needed to elucidate mechanistic interactions among the upper respiratory and middle ear microbiomes. Minimum reporting standards are critically needed to improve inter-study comparisons and enable future meta-analyses.

Citing Articles

Advancements related to probiotics for preventing and treating recurrent respiratory tract infections in children.

Zhang Y, Xu Y, Ling Hu , Wang X Front Pediatr. 2025; 13:1508613.

PMID: 39981209 PMC: 11839809. DOI: 10.3389/fped.2025.1508613.


Draft genome sequence of novel Candidatus Ornithobacterium hominis carrying antimicrobial resistance genes in Egypt.

Ahmed N, Azab M, Enany S, Hanora A BMC Microbiol. 2024; 24(1):47.

PMID: 38302869 PMC: 10835994. DOI: 10.1186/s12866-023-03172-6.


Realising respiratory microbiomic meta-analyses: time for a standardised framework.

Broderick D, Marsh R, Waite D, Pillarisetti N, Chang A, Taylor M Microbiome. 2023; 11(1):57.

PMID: 36945040 PMC: 10031919. DOI: 10.1186/s40168-023-01499-w.


The adult microbiome of healthy and otitis patients: Definition of the core healthy and diseased ear microbiomes.

Burton M, Krumbeck J, Wu G, Tang S, Prem A, Gupta A PLoS One. 2022; 17(1):e0262806.

PMID: 35073343 PMC: 8786117. DOI: 10.1371/journal.pone.0262806.


Innate Immunity in the Middle Ear Mucosa.

Massa H, Spann K, Cripps A Front Cell Infect Microbiol. 2021; 11:764772.

PMID: 34778109 PMC: 8586084. DOI: 10.3389/fcimb.2021.764772.


References
1.
Tarabichi Y, Li K, Hu S, Nguyen C, Wang X, Elashoff D . The administration of intranasal live attenuated influenza vaccine induces changes in the nasal microbiota and nasal epithelium gene expression profiles. Microbiome. 2015; 3:74. PMC: 4678663. DOI: 10.1186/s40168-015-0133-2. View

2.
Gregori G, Righi O, Risso P, Boiardi G, Demuru G, Ferzetti A . Reduction of group A beta-hemolytic streptococcus pharyngo-tonsillar infections associated with use of the oral probiotic Streptococcus salivarius K12: a retrospective observational study. Ther Clin Risk Manag. 2016; 12:87-92. PMC: 4725641. DOI: 10.2147/TCRM.S96134. View

3.
Brooks J, Edwards D, Harwich Jr M, Rivera M, Fettweis J, Serrano M . The truth about metagenomics: quantifying and counteracting bias in 16S rRNA studies. BMC Microbiol. 2015; 15:66. PMC: 4433096. DOI: 10.1186/s12866-015-0351-6. View

4.
Toivonen L, Karppinen S, Schuez-Havupalo L, Teros-Jaakkola T, Vuononvirta J, Mertsola J . Burden of Recurrent Respiratory Tract Infections in Children: A Prospective Cohort Study. Pediatr Infect Dis J. 2016; 35(12):e362-e369. DOI: 10.1097/INF.0000000000001304. View

5.
Devine V, Cleary D, Jefferies J, Anderson R, Morris D, Tuck A . The rise and fall of pneumococcal serotypes carried in the PCV era. Vaccine. 2017; 35(9):1293-1298. DOI: 10.1016/j.vaccine.2017.01.035. View